| Financial Year |
March 31 2023 |
| Monetary Funds |
348,405,597.99 |
| Held-for-trading Financial Assets |
210,344,419.94 |
| Notes Receivable |
-- |
| Accounts Receivable |
48,081,461.85 |
| Advances to Suppliers |
25,472,914.72 |
| Other Receivables |
9,175,358.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,564,084.55 |
| Total Current Assets |
645,043,837.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,762,655.31 |
| Long-term Equity Investment |
55,529,026.29 |
| Investment Properties |
12,442,408.66 |
| Fixed Assetes |
313,350,804.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,486,490.84 |
| R&D expenses |
-- |
| Goodwill |
316,434,159.99 |
| Long-Term Deferred and Prepaid Expenses |
5,085,156.54 |
| Deferred Income Tax Assets |
6,843,870.88 |
| Other Non-Current Assets |
13,737,834.16 |
| Sub-Total of Non-Current Assets |
877,116,733.62 |
| Total Assets |
1,522,160,570.99 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,686,474.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,552,256.47 |
| Taxes Payable |
10,273,994.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,995,387.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,390,616.75 |
| Other Current Liabilities |
1,094,135.36 |
| Sub-Total of Current Liabilities |
155,017,724.00 |
| Long-term Loans |
-- |
| Bonds Payable |
376,454,151.49 |
| Long-Term Accounts Payable |
51,600,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,363,732.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
452,837,689.91 |
| Total Liabilities |
607,855,413.91 |
| Paid-In Capital(Or Share Stock) |
129,906,328.00 |
| Capital Surplus |
260,393,658.19 |
| Surplus Reserve |
47,988,293.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
457,767,688.20 |
| Minority Stockholder's Interest |
789,614.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
913,515,542.93 |
| Owner's Equity（Stockholder's Equity） |
914,305,157.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,522,160,570.99 |
